Anatomy Quiz: Cell Signaling Basics Receptors Second Messengers
11 questions · exam conditions
0:00
Cell Signaling Basics Receptors Second MessengersQuestion 1 of 11

A steroid hormone enters a target cell and binds to its cytoplasmic receptor. However, the cell shows no response to the hormone. Which factor is most likely responsible for this lack of response?

The hormone concentration in the blood is too low to be effective
The receptor-hormone complex cannot enter the nucleus due to nuclear membrane damage
The cell lacks sufficient ATP to power the hormone response mechanisms
The hormone is binding to the wrong type of receptor in the cytoplasm
The cell membrane is preventing the hormone from entering the cytoplasm
← Back to quizzes

Anatomy Quiz

Anatomy Quiz: Cell Signaling Basics Receptors Second Messengers

Practice Cell Signaling Basics Receptors Second Messengers in Anatomy with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Cell Signaling Basics Receptors Second Messengers, giving you a quick way to practice the rules, question types, and explanations that matter most for Anatomy.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A steroid hormone enters a target cell and binds to its cytoplasmic receptor. However, the cell shows no response to the hormone. Which factor is most likely responsible for this lack of response?

  1. The hormone concentration in the blood is too low to be effective
  2. The receptor-hormone complex cannot enter the nucleus due to nuclear membrane damage (correct answer)
  3. The cell lacks sufficient ATP to power the hormone response mechanisms
  4. The hormone is binding to the wrong type of receptor in the cytoplasm
  5. The cell membrane is preventing the hormone from entering the cytoplasm
Explanation: When you encounter questions about steroid hormone action, focus on the complete pathway: hormone binding, nuclear entry, and gene transcription. Steroid hormones work by forming receptor-hormone complexes that must translocate to the nucleus to regulate gene expression. The scenario describes a hormone that successfully binds to its cytoplasmic receptor but produces no cellular response. Since binding occurred normally, the problem must lie in a subsequent step of the signaling pathway. For steroid hormones, the critical next step is nuclear entry, where the receptor-hormone complex acts as a transcription factor to modify gene expression. If the nuclear membrane is damaged and prevents this complex from entering the nucleus, no gene transcription changes occur, resulting in no cellular response despite successful hormone-receptor binding. Looking at the other options: (A) is incorrect because the hormone successfully bound to its receptor, indicating sufficient concentration reached the target cell. (D) is wrong since the question states the hormone binds to "its cytoplasmic receptor," meaning it's the correct receptor type. (C) misunderstands steroid hormone mechanisms—while ATP is needed for many cellular processes, the initial steps of steroid hormone action (binding and nuclear entry) don't require significant ATP expenditure. For anatomy and physiology exams, remember that steroid hormone questions often test your understanding of the complete signaling pathway, not just receptor binding. Always consider what happens after the initial hormone-receptor interaction—successful binding is just the first step in a multi-stage process.

Question 2

A hormone binds to its receptor on the cell surface and activates adenylyl cyclase. If the cell's ATP levels are severely depleted due to metabolic stress, which outcome is most likely?

  1. The hormone-receptor binding will be completely blocked
  2. The second messenger response will be significantly reduced despite normal receptor binding (correct answer)
  3. The receptor will internalize faster to compensate for the metabolic stress
  4. The hormone will switch to using a different receptor type on the same cell
  5. The cell membrane potential will immediately depolarize to restore ATP levels
Explanation: When you encounter questions about hormone signaling pathways, focus on the sequential steps: hormone binding, receptor activation, enzyme activation, and second messenger production. Each step depends on the previous one, but they can fail independently. This question tests your understanding of the cAMP signaling pathway. When a hormone binds to its G-protein coupled receptor, it activates adenylyl cyclase, which converts ATP into cyclic AMP (cAMP) - the second messenger. If ATP levels are severely depleted, adenylyl cyclase has no substrate to work with, even though the hormone can still bind normally and the receptor can still activate the enzyme. The correct answer is B because the hormone-receptor binding and initial signal transduction remain intact, but the production of cAMP (the second messenger) becomes severely limited due to lack of ATP substrate. The cell maintains its receptor function but loses its ability to generate the downstream response. Answer A is incorrect because hormone-receptor binding doesn't require ATP - it depends on molecular recognition and affinity. Answer C is wrong because receptor internalization isn't a compensatory mechanism for ATP depletion; it's typically part of receptor desensitization or recycling. Answer D is incorrect because hormones have specific receptor types they bind to based on molecular structure - ATP levels don't change this specificity. Remember: ATP depletion affects enzymatic processes that require ATP as substrate, not the earlier binding and recognition steps. Always trace through signaling pathways step-by-step to identify where the disruption occurs.

Question 3

A researcher is studying two different cell types that both respond to the same hormone. Cell type A shows a rapid response within seconds, while cell type B shows a slower response taking several minutes. What is the most likely explanation for this difference?

  1. Cell type A has more hormone receptors on its surface than cell type B
  2. Cell type A uses intracellular receptors while cell type B uses membrane receptors
  3. Cell type A uses membrane receptors while cell type B uses intracellular receptors (correct answer)
  4. Cell type B has a higher affinity for the hormone than cell type A
  5. Cell type A produces more second messenger molecules per receptor activation
Explanation: When you encounter questions about hormone response timing, focus on the fundamental difference between membrane-bound and intracellular receptor mechanisms. The speed of cellular response directly correlates with where the hormone receptors are located and how they trigger cellular changes. Cell type A's rapid response (seconds) indicates it uses membrane receptors. When hormones like epinephrine bind to surface receptors, they immediately activate intracellular signaling cascades through second messengers like cAMP. These cascades can instantly modify existing enzymes through phosphorylation, producing immediate effects without requiring new protein synthesis. Cell type B's slower response (minutes) suggests intracellular receptors. Steroid hormones like cortisol must first cross the cell membrane, bind to cytoplasmic or nuclear receptors, then migrate to the nucleus where the hormone-receptor complex acts as a transcription factor. This process requires gene transcription, mRNA processing, and protein synthesis—all time-consuming steps that explain the delayed response. Choice A is incorrect because receptor quantity affects response magnitude, not speed. Choice B reverses the relationship—intracellular receptors actually produce slower responses, not faster ones. Choice D is wrong because higher receptor affinity would enhance sensitivity to lower hormone concentrations but wouldn't fundamentally change the response timeline, which is determined by the mechanism of action. Remember this pattern: membrane receptors = rapid responses (seconds to minutes), intracellular receptors = slower responses (minutes to hours). The location determines the mechanism, and the mechanism determines the timing.

Question 4

A cell biologist observes that when calcium levels in the cytoplasm increase from 0.1 μM to 1.0 μM, a particular cellular response is triggered. However, when calcium increases from 1.0 μM to 10.0 μM, no additional response occurs. This pattern most likely indicates:

  1. The calcium-binding proteins have reached saturation at 1.0 μM concentration (correct answer)
  2. High calcium concentrations are toxic and shut down cellular responses
  3. The cell has run out of ATP needed to maintain the calcium response
  4. Calcium pumps are actively removing excess calcium above 1.0 μM
  5. The calcium is binding to inhibitory sites at concentrations above 1.0 μM
Explanation: When you encounter questions about cellular responses to increasing concentrations of signaling molecules like calcium, think about the dose-response relationship and the concept of receptor saturation. Cells typically respond to signals through specific binding proteins or receptors, which have limited capacity. The pattern described here—where the cellular response occurs when calcium increases from 0.1 μM to 1.0 μM but no additional response happens when calcium rises further to 10.0 μM—is classic evidence of protein saturation. At 1.0 μM, all available calcium-binding sites on the response proteins are occupied, so adding more calcium cannot produce additional responses. This makes option A correct. Option B incorrectly assumes toxicity is shutting down responses, but the question states no additional response occurs, not that responses are being inhibited or stopped. Option C misinterprets the scenario—the issue isn't ATP depletion preventing response maintenance, but rather the absence of any additional response despite more calcium being available. Option D focuses on calcium removal mechanisms, but calcium pumps wouldn't selectively activate only above 1.0 μM, and pump activity wouldn't explain why the initial response plateaus rather than decreases. This saturation pattern appears throughout physiology—from enzyme kinetics to hormone responses. When you see a biological response that increases with stimulus intensity but then plateaus despite continued stimulus increases, immediately consider whether the responding system has reached its maximum capacity. Remember: saturation curves are fundamental to understanding how cells process chemical signals.

Question 5

A pharmaceutical company develops a drug that acts as a competitive inhibitor of a hormone receptor. In the presence of this drug, increasing the concentration of the natural hormone can still produce a normal maximum response. What does this tell us about the drug's mechanism of action?

  1. The drug permanently damages the receptor structure and prevents all hormone binding
  2. The drug binds to the same site as the hormone but can be displaced by higher hormone concentrations (correct answer)
  3. The drug enhances the receptor's sensitivity to the hormone at high concentrations
  4. The drug blocks the second messenger pathway downstream of the receptor
  5. The drug causes the receptor to internalize and become unavailable for binding
Explanation: When you encounter questions about receptor inhibition and dose-response relationships, focus on how different types of inhibitors affect the ability to restore normal function with increased ligand concentration. The key insight here is that increasing hormone concentration can still produce a normal maximum response despite the inhibitor's presence. This pattern is the hallmark of competitive inhibition. In competitive inhibition, the drug competes with the natural hormone for the same binding site on the receptor. When hormone concentrations are low, the drug successfully competes and blocks many receptors. However, as you increase hormone concentration, the natural hormone can outcompete the drug and displace it from the binding sites, eventually achieving full receptor activation and normal maximum response. This is exactly what option B describes. Option A is wrong because permanent receptor damage would prevent any normal response, regardless of hormone concentration. Option C incorrectly suggests the drug enhances sensitivity—competitive inhibitors reduce apparent sensitivity by requiring higher concentrations to achieve the same effect, but they don't enhance it. Option D describes non-competitive inhibition affecting downstream signaling, which would prevent achieving normal maximum response even at high hormone concentrations. The critical study tip for receptor pharmacology: competitive inhibitors shift dose-response curves to the right (requiring higher concentrations) but preserve the maximum response, while non-competitive inhibitors reduce the maximum response regardless of concentration. Always ask yourself whether increasing the natural ligand can overcome the inhibition completely.

Question 6

A research study examines cells that express both α-adrenergic and β-adrenergic receptors. When norepinephrine binds to α-adrenergic receptors, it activates phospholipase C. When it binds to β-adrenergic receptors, it activates adenylyl cyclase. If a cell is treated with norepinephrine in the presence of a β-adrenergic receptor blocker, which outcome is most likely?

  1. Both cAMP and IP3/DAG levels will increase proportionally to normal conditions
  2. cAMP levels will increase while IP3/DAG levels remain at baseline
  3. IP3/DAG levels will increase while cAMP levels remain at baseline (correct answer)
  4. Neither cAMP nor IP3/DAG levels will change from baseline
  5. Both second messenger systems will be activated but at reduced levels
Explanation: When you encounter questions about adrenergic receptors and second messenger systems, focus on the distinct signaling pathways each receptor type activates and how blocking one pathway affects the others. In this scenario, norepinephrine can bind to both receptor types, but the β-adrenergic blocker prevents it from accessing β-adrenergic receptors. This means norepinephrine can only bind to the available α-adrenergic receptors, which activate phospholipase C and produce IP3/DAG as second messengers. Since the β-adrenergic pathway (which produces cAMP via adenylyl cyclase) is blocked, cAMP levels remain at baseline while IP3/DAG levels increase above baseline. Answer C correctly identifies this outcome: IP3/DAG levels increase while cAMP levels remain at baseline. Answer A is wrong because it suggests both pathways remain proportionally active, ignoring the β-blocker's effect. Answer B reverses the actual outcome—it incorrectly suggests the blocked β-pathway (cAMP) increases while the available α-pathway (IP3/DAG) stays flat. Answer D assumes the blocker prevents all norepinephrine signaling, but it only blocks β-receptors, leaving α-receptors fully functional. For anatomy and physiology exams, remember that receptor blockers are pathway-specific. When one pathway is blocked, the ligand doesn't disappear—it's redirected to available receptors. Always trace which second messenger system each receptor activates: α-adrenergic receptors → phospholipase C → IP3/DAG, and β-adrenergic receptors → adenylyl cyclase → cAMP.

Question 7

In a laboratory experiment, researchers find that a particular second messenger has a very short half-life of only 3 seconds in the cytoplasm. Despite this rapid degradation, the cellular response to this messenger lasts for several minutes. What mechanism most likely explains this sustained response?

  1. The second messenger is continuously regenerated as long as the receptor remains activated
  2. The second messenger becomes protected from degradation by binding to cellular proteins
  3. The degradation enzymes become saturated and cannot process the second messenger effectively
  4. The second messenger activates enzymes that remain active after the messenger is degraded (correct answer)
  5. The cell membrane prevents the second messenger from being exported out of the cell
Explanation: When you encounter questions about signal transduction timing, focus on the relationship between messenger lifespan and response duration. The key insight here is that short-lived messengers can trigger long-lasting effects through enzyme activation cascades. The correct answer is D because second messengers often function by activating enzymes (like protein kinases) that continue working long after the original messenger is degraded. Think of it like lighting a candle with a match—once the enzyme is activated, it keeps catalyzing reactions even though the second messenger that activated it is gone. This explains how a 3-second messenger can produce minutes of cellular response. Option A is incorrect because continuous regeneration would require the receptor to stay activated for minutes, which contradicts the premise of a short-lived response. Option B misunderstands the mechanism—while some messengers do bind protective proteins, this would extend the messenger's half-life, not explain sustained effects despite rapid degradation. Option C suggests enzyme saturation, but if degradation enzymes were overwhelmed, the messenger would accumulate and have a longer effective half-life, contradicting the 3-second measurement. The classic example is cAMP activating protein kinase A—once PKA is activated, it phosphorylates multiple target proteins and remains active even as cAMP levels drop. This amplification through enzyme cascades is fundamental to cell signaling. Remember: in signal transduction questions, distinguish between the messenger's lifespan and the response duration. Short-lived messengers often trigger enzyme cascades that outlast the original signal.

Question 8

An experimental drug is designed to mimic the action of IP3 (inositol trisphosphate) in cells. If this drug is applied to cells in a calcium-free medium, what would be the most likely immediate effect?

  1. Massive calcium influx from outside the cell leading to cellular damage
  2. Temporary increase in cytoplasmic calcium followed by rapid depletion of intracellular stores (correct answer)
  3. No change in cytoplasmic calcium levels since the drug requires extracellular calcium
  4. Sustained elevation of cytoplasmic calcium through enhanced calcium production
  5. Gradual increase in calcium levels as the drug stimulates calcium synthesis
Explanation: When you encounter questions about IP3 and calcium signaling, focus on understanding the two main sources of cellular calcium: extracellular influx and intracellular stores in the endoplasmic reticulum (ER). IP3 is a second messenger that specifically binds to receptors on the ER membrane, causing calcium channels to open and release stored calcium into the cytoplasm. This mechanism is independent of extracellular calcium availability. When the experimental drug mimics IP3 action in a calcium-free medium, it will trigger calcium release from internal ER stores, causing an initial spike in cytoplasmic calcium. However, since there's no extracellular calcium to replenish the ER stores and the cell continues its normal calcium-clearing mechanisms, the stores will become depleted, leading to a rapid decline in cytoplasmic calcium levels. Answer A is incorrect because IP3 doesn't directly cause calcium influx from outside the cell—it releases internal stores. Answer C misunderstands IP3's mechanism; IP3 action doesn't require extracellular calcium since it targets internal stores. Answer D is wrong because cells don't "produce" calcium—they only move it between compartments, and without external calcium to replenish stores, elevation cannot be sustained. The correct answer is B: you'll see a temporary calcium spike followed by depletion as internal stores empty without replenishment. Remember: IP3 always targets internal calcium stores first, regardless of external calcium availability. This distinction between internal release and external influx is crucial for understanding calcium signaling pathways.

Question 9

Two hormones, X and Y, both activate the same G-protein coupled receptor on liver cells, but hormone X activates adenylyl cyclase while hormone Y activates phospholipase C. What best explains this difference in second messenger pathways?

  1. The hormones bind to different conformational states of the same receptor protein
  2. The hormones activate different subtypes of G-proteins coupled to the same receptor (correct answer)
  3. Hormone X has higher binding affinity than hormone Y for the receptor
  4. The hormones are binding to the receptor at different times of day
  5. Hormone Y requires a co-factor that hormone X does not need
Explanation: When you encounter questions about G-protein coupled receptors (GPCRs) and different signaling pathways, focus on the relationship between receptor subtypes, G-protein types, and their downstream effects. GPCRs can couple to different G-protein subtypes, each triggering distinct second messenger cascades. The key insight here is that a single receptor can associate with multiple G-protein subtypes depending on various factors like tissue type, receptor expression levels, or cellular conditions. When hormone X activates adenylyl cyclase, it's likely coupling through Gs proteins, which stimulate cAMP production. When hormone Y activates phospholipase C, it's coupling through Gq/11 proteins, which cleave PIP2 to generate IP3 and DAG. This explains why the same receptor produces different second messenger pathways. Option A incorrectly suggests conformational states of the receptor determine the pathway, but it's the G-protein type, not receptor conformation, that determines downstream signaling. Option C focuses on binding affinity, which affects signal strength but not which second messenger pathway is activated. Option D proposes circadian timing as the factor, but time of day doesn't change fundamental G-protein coupling mechanisms. The correct answer is B because different G-protein subtypes coupled to the same receptor account for the distinct second messenger pathways. For anatomy and physiology exams, remember that GPCR signaling flexibility often comes from G-protein diversity, not receptor diversity. When you see questions about different pathways from similar stimuli, think about which G-protein subtype is involved.

Question 10

A patient receives a drug that blocks phosphodiesterase, the enzyme that breaks down cAMP. If this patient is then given a hormone that normally activates adenylyl cyclase, what would be the expected outcome compared to normal conditions?

  1. The hormone response will be completely blocked due to drug interference
  2. The hormone response will be normal in magnitude but shorter in duration
  3. The hormone response will be enhanced in both magnitude and duration (correct answer)
  4. The hormone response will be reduced in magnitude but longer in duration
  5. The hormone will be unable to bind to its receptor effectively
Explanation: When you encounter questions about second messenger systems, focus on the cascade effect and how blocking specific enzymes affects the entire pathway. The cAMP signaling pathway works like this: hormone binds to receptor → activates adenylyl cyclase → increases cAMP production → activates protein kinase A → cellular response. Normally, phosphodiesterase breaks down cAMP to terminate the signal. The correct answer is C because blocking phosphodiesterase creates a "double hit" effect. First, the hormone still activates adenylyl cyclase normally, producing cAMP at the usual rate. Second, since phosphodiesterase is blocked, cAMP isn't being broken down as it should be. This means cAMP levels build up much higher than normal (enhanced magnitude) and stay elevated much longer (enhanced duration). More cAMP means more protein kinase A activation and a stronger, longer-lasting cellular response. Option A is wrong because the drug doesn't interfere with the hormone-receptor interaction or adenylyl cyclase activity. Option B incorrectly suggests normal magnitude—blocking breakdown would actually increase magnitude—and shorter duration, when preventing cAMP degradation would extend the response. Option D gets the duration right (longer) but wrongly predicts reduced magnitude; blocking the enzyme that removes cAMP would increase, not decrease, the response strength. Remember this pattern: when an exam asks about blocking enzymes that degrade second messengers, the result is always enhanced signaling. Think of it as removing the "brakes" from the system—everything gets amplified.

Question 11

A cell line is engineered to lack functional G-proteins but retains normal hormone receptors. When exposed to a hormone that normally activates adenylyl cyclase through a G-protein coupled receptor, what response would be expected?

  1. Normal cAMP production and cellular response since the receptor is intact
  2. Reduced cAMP production but normal cellular response to compensate
  3. Normal hormone binding but no cAMP production or cellular response (correct answer)
  4. Complete blockade of hormone binding to the receptor due to lack of G-proteins
  5. Enhanced cAMP production as the cell overcompensates for missing G-proteins
Explanation: When you encounter questions about G-protein coupled receptor (GPCR) signaling, focus on the sequential steps: hormone binding → receptor activation → G-protein activation → second messenger production → cellular response. Each step depends on the previous one functioning properly. In this engineered cell line, the hormone can still bind to its receptor because binding depends only on the receptor's structure, not on G-proteins. The receptor-hormone complex forms normally and may even undergo conformational changes. However, without functional G-proteins, the signal cannot be transmitted to adenylyl cyclase. G-proteins act as essential molecular switches that relay the signal from the activated receptor to adenylyl cyclase, which produces cAMP. No G-proteins means no cAMP production, and without this crucial second messenger, no downstream cellular response occurs. Answer A is incorrect because cAMP production requires functional G-proteins to activate adenylyl cyclase, regardless of receptor integrity. Answer B wrongly assumes some cAMP production is possible and that cells can compensate for missing second messengers. Answer D misunderstands the binding mechanism - hormone-receptor binding is a direct molecular interaction that doesn't require G-proteins. The correct answer is C: normal hormone binding occurs, but the signaling cascade stops there, resulting in no cAMP production or cellular response. Study tip: Remember that GPCR signaling is like a relay race - if any runner (component) is missing, the baton (signal) can't reach the finish line, even if the starting runner (receptor) receives it perfectly.